Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors (Q39125740)

9 September 2017

title

Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors (English)

1 reference

9 September 2017

0 references

Michael A Letavic

1

1 reference

9 September 2017

John T Barberia

2

1 reference

9 September 2017

Thomas J Carty

3

1 reference

9 September 2017

Joel R Hardink

4

1 reference

9 September 2017

Jennifer Liras

5

1 reference

9 September 2017

Lori L Lopresti-Morrow

6

1 reference

9 September 2017

Peter G Mitchell

7

1 reference

9 September 2017

Mark C Noe

8

1 reference

9 September 2017

Lisa M Reeves

9

1 reference

9 September 2017

Sheri L Snow

10

1 reference

9 September 2017

Ethan J Stam

11

1 reference

9 September 2017

Francis J Sweeney

12

1 reference

9 September 2017

Marcie L Vaughn

13

1 reference

9 September 2017

Chul H Yu

14

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

9 September 2017

published in

1 reference

9 September 2017

volume

13

1 reference

9 September 2017

issue

19

1 reference

9 September 2017

page(s)

3243-3246

1 reference

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Benzodiazepine inhibitors of the MMPs and TACE.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

Design and synthesis of piperazine-based matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900666-8

7 January 2021

10.1016/S0960-894X(03)00666-8

Identifiers

DOI

1 reference

9 September 2017

1 reference